Why Israel

An attractive location for your clinical study

Location Advantages

Why Conduct Your Study in Israel?

10,000+ registered clinical trials on clinicaltrials.gov
  • World-class medical infrastructure and research institutions
  • Highly skilled and experienced clinical investigators
  • Diverse patient population enabling broad enrollment
  • Well-established regulatory framework through the Helsinki Committee and Ministry of Health
  • Full compliance with ICH-GCP
  • High quality data, accepted & inspected by US FDA and EMEA
  • Innovation-driven ecosystem with deep pharma and biotech expertise
Israel on World Map
Israel
Regulatory Framework

How Clinical Trials Are Approved in Israel

Helsinki Committee

The Principal Investigator submits an application for approval to the Helsinki Committee (IRB) at their institution. This is the primary ethical review body for all clinical trials.

Special Trials

Trials defined as "special" under regulations are conveyed for final approval to the Director of the Hospital where the study is conducted.

Non-Special Trials (MoH)

Non-special trials require additional approval from the Director General of the Ministry of Health, via the Clinical Trials Department in the Pharmaceutical Administration.

Start Your Study in Israel

Learn about the regulatory process and timeline.

View Start-up Process